Reflects current rules, regulations, and guidelines in Title 21 of the Code of Federal Regulations and presents the latest advances in expediting drug development procedures. The book is designed to be of interest to research and development personnel in the pharmaceutical industry, including clinical and research pharmacists and pharmacologists, organic, medicinal, cosmetic, analytical, and clinical chemists and biochemists, clinical toxicologists, biostatisticians, government regulatory personnel, international pharmaceutical manufacturers and students in drug development courses.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Emile Kerssemakers ILAB, Heerlen, Niederlande
23 cm. original hardcover. xxii,470 pp. bibliography. references. index. "Drugs and the Pharmaceutical Sciences, a Series of Monographs". -(library stamp, a few small dents in covers, otherwise very good). 805g. Bestandsnummer des Verkäufers 70910
Anzahl: 1 verfügbar
Anbieter: Emile Kerssemakers ILAB, Heerlen, Niederlande
23 cm. original hardcover. xxii,470 pp. bibliography. references. index. "Drugs and the Pharmaceutical Sciences, a Series of Monographs". -(libr labels, library stamp, otherwise very good). 777g. Bestandsnummer des Verkäufers 69953
Anzahl: 1 verfügbar
Anbieter: Better World Books, Mishawaka, IN, USA
Zustand: Good. 2nd Rev/Ex. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. Bestandsnummer des Verkäufers 18159041-6
Anzahl: 1 verfügbar